Immatics N.V. (NASDAQ: IMTX)
$7.6000
+0.0200 ( +0.13% ) 209.0K
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
Market Data
Open
$7.6000
Previous close
$7.5800
Volume
209.0K
Market cap
$920.13M
Day range
$7.5050 - $7.8050
52 week range
$7.4600 - $13.7700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 111 | Nov 18, 2024 |
| 6-k | Form 6-K | 92 | Nov 08, 2024 |
| 6-k | Form 6-K | 10 | Oct 15, 2024 |
| 6-k | Form 6-K | 118 | Oct 10, 2024 |
| 6-k | Form 6-K | 110 | Sep 16, 2024 |
| 6-k | Form 6-K | 78 | Aug 13, 2024 |
| 6-k | Form 6-K | 1 | Jul 31, 2024 |
| 6-k | Form 6-K | 2 | Jun 20, 2024 |
| 6-k | Form 6-K | 7 | Jun 03, 2024 |
| 6-k | Form 6-K | 75 | May 14, 2024 |